High-throughput platform for the discovery of elicitors of silent bacterial gene clusters

Mohammad R. Seyedsayamdost

DOI: https://doi.org/10.1073/pnas.1400019111

IF: 11.1

2014-05-07

Proceedings of the National Academy of Sciences

Abstract:Significance Most clinically used antibiotics are derived from bacterial small molecules produced by dedicated biosynthetic gene clusters. Recent investigations have indicated that the majority of these biosynthetic genes are inactive or “silent.” Identifying the triggers that lead to activation of silent clusters would greatly expand our repertoire of therapeutic molecules. Described herein is a new, high-throughput approach for identifying activators of silent gene clusters. Application of this method to two bacterial clusters revealed that both could be efficiently activated and uncovered a new metabolite. Surprisingly, almost all elicitors discovered were antibiotics, suggesting they play an important role in modulating silent biosynthetic pathways. This approach promises to reveal useful small molecules and the biological regulatory mechanisms underlying silent gene clusters.